We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
APOA5
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • APOA5
PROTEIN SUMMARY GENE INFORMATION RNA DATA
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

APOA5
Synonyms APOA-V, RAP3
Gene descriptioni

Full gene name according to HGNC.

Apolipoprotein A5
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Disease related genes
Human disease related genes
Plasma proteins
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Secreted
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 11
Cytoband q23.3
Chromosome location (bp) 116789367 - 116792420
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

4
Ensembl ENSG00000110243 (version 109)
Entrez gene 116519
HGNC HGNC:17288
UniProt Q6Q788 (UniProt - Evidence at protein level)
neXtProt NX_Q6Q788
GeneCards APOA5
Antibodypedia APOA5 antibodies


PROTEIN FUNCTION
Protein function (UniProt)i

Useful information about the protein provided by UniProt.

Minor apolipoprotein mainly associated with HDL and to a lesser extent with VLDL. May also be associated with chylomicrons. Important determinant of plasma triglyceride (TG) levels by both being a potent stimulator of apo-CII lipoprotein lipase (LPL) TG hydrolysis and an inhibitor of the hepatic VLDL-TG production rate (without affecting the VLDL-apoB production rate) (By similarity). Activates poorly lecithin:cholesterol acyltransferase (LCAT) and does not enhance efflux of cholesterol from macrophages. Binds heparin 1.... show less
Biological process (UniProt)i

Keywords assigned by UniProt to proteins because they are involved in a particular biological process.

Lipid transport, Transport
Gene summary (Entrez)i

Useful information about the gene from Entrez

The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Oct 2009]... show less
PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The Splice variant identifier links to the Ensembl website protein summary for the selected splice variant. The data in the Swissprot and TrEMBL columns links to corresponding pages in the UniProt database.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide and number of predicted transmembrane region(s) according to in-house majority decision methods based on sets of predictors are also reported.
Splice variant SwissProt TrEMBL Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
APOA5-201
ENSP00000227665
ENST00000227665
Q6Q788
[Direct mapping] Apolipoprotein A-V
Show all
A0A0B4RUS7
[Target identity:100%; Query identity:100%] Apolipoprotein A-V, isoform CRA_a; Apolipoprotein A5
Show all
   MEMSAT3 predicted membrane proteins
Predicted secreted proteins
   Secreted proteins predicted by MDSEC
   SignalP predicted secreted proteins
   Phobius predicted secreted proteins
   SPOCTOPUS predicted secreted proteins
   DeepTMHMM predicted secreted proteins
   DeepSig predicted secreted proteins
Plasma proteins
Disease related genes
Human disease related genes
   Congenital disorders of metabolism
   Congenital disorders of lipid/glycolipid metabolism
   Endocrine and metabolic diseases
   Other endocrine and metabolic diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005543 [phospholipid binding]
GO:0005576 [extracellular region]
GO:0005615 [extracellular space]
GO:0005768 [endosome]
GO:0005769 [early endosome]
GO:0005770 [late endosome]
GO:0005788 [endoplasmic reticulum lumen]
GO:0005794 [Golgi apparatus]
GO:0006641 [triglyceride metabolic process]
GO:0006695 [cholesterol biosynthetic process]
GO:0006869 [lipid transport]
GO:0008047 [enzyme activator activity]
GO:0008201 [heparin binding]
GO:0008289 [lipid binding]
GO:0010898 [positive regulation of triglyceride catabolic process]
GO:0010902 [positive regulation of very-low-density lipoprotein particle remodeling]
GO:0015485 [cholesterol binding]
GO:0019433 [triglyceride catabolic process]
GO:0019899 [enzyme binding]
GO:0030300 [regulation of intestinal cholesterol absorption]
GO:0031210 [phosphatidylcholine binding]
GO:0033344 [cholesterol efflux]
GO:0033700 [phospholipid efflux]
GO:0034361 [very-low-density lipoprotein particle]
GO:0034364 [high-density lipoprotein particle]
GO:0034370 [triglyceride-rich lipoprotein particle remodeling]
GO:0034372 [very-low-density lipoprotein particle remodeling]
GO:0034380 [high-density lipoprotein particle assembly]
GO:0035473 [lipase binding]
GO:0042157 [lipoprotein metabolic process]
GO:0042246 [tissue regeneration]
GO:0042627 [chylomicron]
GO:0042632 [cholesterol homeostasis]
GO:0045723 [positive regulation of fatty acid biosynthetic process]
GO:0046470 [phosphatidylcholine metabolic process]
GO:0046889 [positive regulation of lipid biosynthetic process]
GO:0048260 [positive regulation of receptor-mediated endocytosis]
GO:0050750 [low-density lipoprotein particle receptor binding]
GO:0050996 [positive regulation of lipid catabolic process]
GO:0051006 [positive regulation of lipoprotein lipase activity]
GO:0055090 [acylglycerol homeostasis]
GO:0060228 [phosphatidylcholine-sterol O-acyltransferase activator activity]
GO:0060229 [lipase activator activity]
GO:0060230 [lipoprotein lipase activator activity]
GO:0070325 [lipoprotein particle receptor binding]
GO:0070328 [triglyceride homeostasis]
Show all
366 aa
41.2 kDa
Yes 0
APOA5-202
ENSP00000399701
ENST00000433069
Q6Q788
[Direct mapping] Apolipoprotein A-V
Show all
A0A0B4RUS7
[Target identity:100%; Query identity:100%] Apolipoprotein A-V, isoform CRA_a; Apolipoprotein A5
Show all
   MEMSAT3 predicted membrane proteins
Predicted secreted proteins
   Secreted proteins predicted by MDSEC
   SignalP predicted secreted proteins
   Phobius predicted secreted proteins
   SPOCTOPUS predicted secreted proteins
   DeepTMHMM predicted secreted proteins
   DeepSig predicted secreted proteins
Plasma proteins
Disease related genes
Human disease related genes
   Congenital disorders of metabolism
   Congenital disorders of lipid/glycolipid metabolism
   Endocrine and metabolic diseases
   Other endocrine and metabolic diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005543 [phospholipid binding]
GO:0005576 [extracellular region]
GO:0005615 [extracellular space]
GO:0005768 [endosome]
GO:0005769 [early endosome]
GO:0005770 [late endosome]
GO:0005788 [endoplasmic reticulum lumen]
GO:0005794 [Golgi apparatus]
GO:0006641 [triglyceride metabolic process]
GO:0006695 [cholesterol biosynthetic process]
GO:0006869 [lipid transport]
GO:0008047 [enzyme activator activity]
GO:0008201 [heparin binding]
GO:0008289 [lipid binding]
GO:0010898 [positive regulation of triglyceride catabolic process]
GO:0010902 [positive regulation of very-low-density lipoprotein particle remodeling]
GO:0015485 [cholesterol binding]
GO:0019433 [triglyceride catabolic process]
GO:0019899 [enzyme binding]
GO:0030300 [regulation of intestinal cholesterol absorption]
GO:0031210 [phosphatidylcholine binding]
GO:0033344 [cholesterol efflux]
GO:0033700 [phospholipid efflux]
GO:0034361 [very-low-density lipoprotein particle]
GO:0034364 [high-density lipoprotein particle]
GO:0034372 [very-low-density lipoprotein particle remodeling]
GO:0034380 [high-density lipoprotein particle assembly]
GO:0035473 [lipase binding]
GO:0042157 [lipoprotein metabolic process]
GO:0042246 [tissue regeneration]
GO:0042627 [chylomicron]
GO:0042632 [cholesterol homeostasis]
GO:0045723 [positive regulation of fatty acid biosynthetic process]
GO:0046470 [phosphatidylcholine metabolic process]
GO:0046889 [positive regulation of lipid biosynthetic process]
GO:0048260 [positive regulation of receptor-mediated endocytosis]
GO:0050750 [low-density lipoprotein particle receptor binding]
GO:0050996 [positive regulation of lipid catabolic process]
GO:0051006 [positive regulation of lipoprotein lipase activity]
GO:0055090 [acylglycerol homeostasis]
GO:0060228 [phosphatidylcholine-sterol O-acyltransferase activator activity]
GO:0060229 [lipase activator activity]
GO:0060230 [lipoprotein lipase activator activity]
GO:0070325 [lipoprotein particle receptor binding]
GO:0070328 [triglyceride homeostasis]
Show all
366 aa
41.2 kDa
Yes 0
APOA5-203
ENSP00000445002
ENST00000542499
Q6Q788
[Direct mapping] Apolipoprotein A-V
Show all
A0A0B4RUS7
[Target identity:100%; Query identity:100%] Apolipoprotein A-V, isoform CRA_a; Apolipoprotein A5
Show all
   MEMSAT3 predicted membrane proteins
Predicted secreted proteins
   Secreted proteins predicted by MDSEC
   SignalP predicted secreted proteins
   Phobius predicted secreted proteins
   SPOCTOPUS predicted secreted proteins
   DeepTMHMM predicted secreted proteins
   DeepSig predicted secreted proteins
Plasma proteins
Disease related genes
Human disease related genes
   Congenital disorders of metabolism
   Congenital disorders of lipid/glycolipid metabolism
   Endocrine and metabolic diseases
   Other endocrine and metabolic diseases
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005515 [protein binding]
GO:0005543 [phospholipid binding]
GO:0005576 [extracellular region]
GO:0005615 [extracellular space]
GO:0005768 [endosome]
GO:0005769 [early endosome]
GO:0005770 [late endosome]
GO:0005788 [endoplasmic reticulum lumen]
GO:0005794 [Golgi apparatus]
GO:0006641 [triglyceride metabolic process]
GO:0006695 [cholesterol biosynthetic process]
GO:0006869 [lipid transport]
GO:0008047 [enzyme activator activity]
GO:0008201 [heparin binding]
GO:0008289 [lipid binding]
GO:0010898 [positive regulation of triglyceride catabolic process]
GO:0010902 [positive regulation of very-low-density lipoprotein particle remodeling]
GO:0015485 [cholesterol binding]
GO:0019433 [triglyceride catabolic process]
GO:0019899 [enzyme binding]
GO:0030300 [regulation of intestinal cholesterol absorption]
GO:0031210 [phosphatidylcholine binding]
GO:0033344 [cholesterol efflux]
GO:0033700 [phospholipid efflux]
GO:0034361 [very-low-density lipoprotein particle]
GO:0034364 [high-density lipoprotein particle]
GO:0034372 [very-low-density lipoprotein particle remodeling]
GO:0034380 [high-density lipoprotein particle assembly]
GO:0035473 [lipase binding]
GO:0042157 [lipoprotein metabolic process]
GO:0042246 [tissue regeneration]
GO:0042627 [chylomicron]
GO:0042632 [cholesterol homeostasis]
GO:0045723 [positive regulation of fatty acid biosynthetic process]
GO:0046470 [phosphatidylcholine metabolic process]
GO:0046889 [positive regulation of lipid biosynthetic process]
GO:0048260 [positive regulation of receptor-mediated endocytosis]
GO:0050750 [low-density lipoprotein particle receptor binding]
GO:0050996 [positive regulation of lipid catabolic process]
GO:0051006 [positive regulation of lipoprotein lipase activity]
GO:0055090 [acylglycerol homeostasis]
GO:0060228 [phosphatidylcholine-sterol O-acyltransferase activator activity]
GO:0060229 [lipase activator activity]
GO:0060230 [lipoprotein lipase activator activity]
GO:0070325 [lipoprotein particle receptor binding]
GO:0070328 [triglyceride homeostasis]
Show all
366 aa
41.2 kDa
Yes 0
APOA5-204
ENSP00000501141
ENST00000673688
A0A669KB69
[Direct mapping] Apolipoprotein A-V
Show all
   MEMSAT3 predicted membrane proteins
Predicted secreted proteins
   Secreted proteins predicted by MDSEC
   SignalP predicted secreted proteins
   Phobius predicted secreted proteins
   SPOCTOPUS predicted secreted proteins
   DeepTMHMM predicted secreted proteins
   DeepSig predicted secreted proteins
Human disease related genes
   Congenital disorders of metabolism
   Congenital disorders of lipid/glycolipid metabolism
   Endocrine and metabolic diseases
   Other endocrine and metabolic diseases
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005576 [extracellular region]
GO:0006869 [lipid transport]
GO:0008289 [lipid binding]
GO:0034364 [high-density lipoprotein particle]
GO:0042157 [lipoprotein metabolic process]
Show all
394 aa
44.3 kDa
Yes 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org